Long-term follow-up of giant cell arteritis and polymyalgia rheumatica complications
Follows adults with giant cell arteritis or polymyalgia rheumatica for aorta and steroid side effects.
Key facts
- Who runs it
- Wuerzburg University Hospital
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Giant Cell Arteritis - Ways to Precision Medicine
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 14 Nov 2025
- Expected to end
- 31 Jul 2033
- Type of study
- Observational, 2 groups
- Record updated
- 22 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). It follows them over a long time to track problems of the aorta and side effects of glucocorticoid (steroid) treatment.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- A main diagnosis of GCA or PMR
- Earlier treatment
- Both people already on immunosuppressive therapy and new patients can join. New patients preferably have not had immunosuppressive therapy, but this is not required.
Main reasons for not taking part
- Under 18 years of age
- Unable to give consent
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Age greater or similar to 18 years
- Primary diagnosis of GCA or PMR
Who cannot take part
- Age under 18 years
- lack of capacity to consent
This trial is currently available in Germany.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
The 2 groups in the trial
- Known patients
Patients, who are already known and had regular visits in the outpatient rheumatology department of the Würzburg university hospital. These patients already receive immunosuppressive therapy.
- New patients
Patients who have not yet been treated by the outpatient rheumatology department of the Würzburg university hospital, preferably but not limited to immunosuppressive therapy-naive patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Riesenzellarteriitis - Wege Zur "Precision Medicine"
- Plain-language title
- Long-term follow-up of giant cell arteritis and polymyalgia rheumatica complicationsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 22 December 2025